Shanghai Shyndec Pharmaceutical Co., Ltd. (SHA:600420)
China
· Delayed Price · Currency is CNY 10.85
+0.02 (0.18%)
At close: Mar 9, 2026
SHA:600420 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 14,552 | 13,546 | 16,014 | 13,130 | 9,346 | 10,650 | Upgrade
|
| Market Cap Growth | -6.95% | -15.41% | 21.96% | 40.50% | -12.25% | 9.04% | Upgrade
|
| Enterprise Value | 12,518 | 11,513 | 13,623 | 10,582 | 10,423 | 12,754 | Upgrade
|
| Last Close Price | 10.85 | 10.10 | 11.62 | 9.35 | 8.61 | 9.71 | Upgrade
|
| PE Ratio | 15.41 | 14.34 | 14.78 | 18.98 | 14.89 | 18.74 | Upgrade
|
| Forward PE | - | 10.42 | 10.42 | 10.42 | 10.42 | 10.42 | Upgrade
|
| PS Ratio | 1.55 | 1.45 | 1.46 | 1.09 | 0.72 | 0.76 | Upgrade
|
| PB Ratio | 0.93 | 0.86 | 1.05 | 0.92 | 0.77 | 1.03 | Upgrade
|
| P/TBV Ratio | 1.14 | 1.06 | 1.29 | 1.12 | 0.97 | 1.35 | Upgrade
|
| P/FCF Ratio | - | - | 7.86 | 9.63 | 3.67 | 9.20 | Upgrade
|
| P/OCF Ratio | - | - | 7.10 | 7.63 | 3.27 | 6.34 | Upgrade
|
| PEG Ratio | - | 0.70 | 0.70 | 0.70 | 0.70 | 0.70 | Upgrade
|
| EV/Sales Ratio | 1.34 | 1.23 | 1.25 | 0.88 | 0.80 | 0.92 | Upgrade
|
| EV/EBITDA Ratio | 6.06 | 5.57 | 5.96 | 5.92 | 6.24 | 6.87 | Upgrade
|
| EV/EBIT Ratio | 9.53 | 8.76 | 8.87 | 10.94 | 12.39 | 11.83 | Upgrade
|
| EV/FCF Ratio | - | - | 6.69 | 7.76 | 4.09 | 11.01 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.07 | 0.08 | 0.28 | 0.40 | Upgrade
|
| Debt / EBITDA Ratio | 0.02 | 0.02 | 0.49 | 0.64 | 2.02 | 2.20 | Upgrade
|
| Debt / FCF Ratio | - | - | 0.56 | 0.84 | 1.34 | 3.61 | Upgrade
|
| Net Debt / Equity Ratio | -0.26 | -0.26 | -0.42 | -0.34 | -0.23 | -0.01 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.98 | -1.98 | -2.84 | -2.70 | -1.64 | -0.05 | Upgrade
|
| Net Debt / FCF Ratio | - | - | -3.19 | -3.54 | -1.08 | -0.09 | Upgrade
|
| Asset Turnover | - | - | 0.56 | 0.62 | 0.67 | 0.75 | Upgrade
|
| Inventory Turnover | - | - | 3.04 | 3.19 | 2.94 | 2.49 | Upgrade
|
| Quick Ratio | - | - | 2.09 | 2.15 | 2.12 | 1.09 | Upgrade
|
| Current Ratio | - | - | 2.69 | 2.82 | 2.79 | 1.59 | Upgrade
|
| Return on Equity (ROE) | 6.09% | 6.09% | 8.98% | 7.28% | 7.70% | 8.13% | Upgrade
|
| Return on Assets (ROA) | - | - | 4.88% | 3.10% | 2.72% | 3.61% | Upgrade
|
| Return on Invested Capital (ROIC) | 8.05% | 9.15% | 13.34% | 9.00% | 7.54% | 9.56% | Upgrade
|
| Return on Capital Employed (ROCE) | - | - | 9.80% | 6.20% | 5.50% | 8.80% | Upgrade
|
| Earnings Yield | 6.49% | 6.97% | 6.77% | 5.27% | 6.72% | 5.34% | Upgrade
|
| FCF Yield | - | - | 12.72% | 10.38% | 27.27% | 10.88% | Upgrade
|
| Dividend Yield | 2.77% | - | 2.58% | 1.07% | 1.16% | 1.03% | Upgrade
|
| Payout Ratio | - | - | 27.75% | 27.37% | 29.42% | 37.39% | Upgrade
|
| Buyback Yield / Dilution | -0.01% | -0.01% | -5.31% | -10.13% | 1.82% | 0.14% | Upgrade
|
| Total Shareholder Return | 2.76% | -0.01% | -2.73% | -9.06% | 2.98% | 1.17% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.